butylscopolammonium bromide has been researched along with Metabolic Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Francisco, FA; Franco, CC; Gomes, RM; Malta, A; Martins, IP; Mathias, PC; Miranda, RA; Natali, MR; Oliveira, JC; Palma-Rigo, K; Pavanello, A; Prates, KV; Previate, C; Ribeiro, TA; Souza, AA; Tófolo, LP | 1 |
1 other study(ies) available for butylscopolammonium bromide and Metabolic Diseases
| Article | Year |
|---|---|
Neonatal treatment with scopolamine butylbromide prevents metabolic dysfunction in male rats.
Topics: Animals; Animals, Newborn; Butylscopolammonium Bromide; Disease Models, Animal; Female; Male; Metabolic Diseases; Obesity; Rats; Rats, Wistar | 2016 |